In the 1970s, the first recombinant DNA was produced. This emergent technology was met with concerns about public healthy and safety, potential environmental effect, and the ethical and social impact of such research. Recombinant DNA is made through the recombination of other genetic material, and otherwise does not exist in nature. The NIH Guidelines for Research Involving Recombinant DNA Molecules were issued in 1976 and multiple revisions have been issued since. The most recent revision was released in November 2013.
Our biosafety unit provides assistance to the University community in assuring that research involving recombinant or synthetic nucleic acid molecules and other biological materials is conducted in a safe and responsible manner, and that these activities are in compliance with the NIH Guidelines and all other external regulations and applicable University policies.
Services provided by the Biosafety unit include:
- IBC application submission and approval
- Biosafety trainings
- Biosafety lab inspections
- Consultation for shipping biological materials
- Provides shipping labels on request
- Laboratory design
- Reminders for autoclave maintenance/spore testing and biosafety cabinet certification
- Biological waste information
For more information: Contact Us
News and Updates
May 25, 2018
New Lab Management and Safety Compliance Application Coming This Summer
Environmental Health and Safety (EH&S) is excited to announce that it will be implementing BioRAFT to make lab management for chemical, biological and radiological safety compliance easier and more user-friendly. BioRAFT is a centralized, web-based platform for EH&S and CU Boulder’s research communities to manage laboratory training, inspections, equipment, hazards and much more. This new […]Read more...
January 2, 2018
January 2018 Occupational Health and Safety (OHSP) Newsletter
The OHSP has recently expanded to include laboratories that conduct biological research. Read more in our newsletter! ohsp-newsletter-january-2018Read more...